Ep 009 | Hilary Beck with Ideaya Biosciences episode artwork

EPISODE · Aug 22, 2017 · 58 MIN

Ep 009 | Hilary Beck with Ideaya Biosciences

from The Marc Guzman Experience

Cancer is currently the second leading cause of death in the United States and quickly approaching to be the #1 cause. For most, treatment includes chemotherapy and radiation that, unfortunately, attacks both cancerous and healthy cells. At the forefront of innovation are companies like IDEAYA Biosciences creating alternative cures to cancer such as synthetic medicines and immunotherapy that target only the cancerous cells. Hilary Beck, Director of Medicinal Chemistry, joins us on the podcast to discuss her field and unique occupation of fighting cancer. Guest: http://bit.ly/2vbAs7C. IDEAYA Biosciences: http://bit.ly/2vbgs53.    

Episode metadata supplied by the publisher feed · Published Aug 22, 2017

Embed this episode

NOW PLAYING

Ep 009 | Hilary Beck with Ideaya Biosciences

0:00 58:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Marc Guzman Experience?

This episode is 58 minutes long.

When was this The Marc Guzman Experience episode published?

This episode was published on August 22, 2017.

Can I download this The Marc Guzman Experience episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!